Solv4U

Solv4U
Product Description

Marinosolv® enables a strongly increased solubilization and thereby enhanced bioavailability of hydrophobic small molecules and peptides. Consequently, more efficient treatments of a multitude of diseases can be envisaged. Marinosolv® technology facilitates targeted drug delivery with a low systemic off-target activity. Existing drugs and off-patent active ingredients can be improved and re-patented as part of new formulations using Marinosolv®.

Read more Show less

Marinomed Biotech AG

  • Country/Region:
    Austria
  • On CPHI since:
    2020
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Medical Devices
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Using Marinosolv® as formulation technology offers several new applications for highly insoluble substances in eyes, lungs, as well as several other sensitive target tissues, resulting in high local activity and low systemic side effects. Marinosolv® may be used for re-formulation and/or re-purposing of established API's enabling life cycle extension of locally applied, locally acting drugs but also for systemic administration routes. 
  • Selling Points
    Marinomed Biotech AG provides Solv4U technology partnerships which address solubility and bioavailability issues and supports formulation development of both well-established API’s and new chemical entities (NCE’s), in all stages of drug development, based on its proprietary innovative Marinosolv® technology platform.
  • Model
    drug delivery technology
More specifications Fewer specifications
Sales Markets
Show more Show less

Marinomed Biotech AG

  • Country/Region:
    Austria
  • On CPHI since:
    2020
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Medical Devices
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Marinomed Biotech AG (2)

  • Tacrosolv – a novel Marinosolv enabled solution

    Product Tacrosolv – a novel Marinosolv enabled solution

    Marinosolv technology significantly extends ocular tissue penetration, enabling a faster onset of efficacy due to high bioavailability of active pharmaceutical ingredients, while enhancing tolerability and safety through a substantial reduction in dosage and minimized systemic exposure.
  • Budesolv

    Product Budesolv

    Marinosolv® – The Enabling Technology Behind BudesolvBudesolv is an innovative aqueous budesonide formulation based on Marinosolv® drug delivery platform, which has the potential to dramatically improve the solubility and bioavailability of poorly water-soluble compounds. This leads to faster therapeu...

Marinomed Biotech AG resources (1)